MedImmune working with NIH on flu vaccines

MedImmune says it will work with the National Institute of Allergy and Infectious Diseases to develop vaccines against flu strains the government believes could develop into widespread problems, in particular the H5N1 avian flu strain. The company already markets an inhaled seasonal flu vaccine, FluMist.

View Full Article in:

Washington Post (tiered subscription model), The · MarketWatch

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Actuary
Meridian Health Plan
Detroit, MI
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC